PlainRecalls
FDA Drug Moderate Class II Ongoing

EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.

Reported: July 30, 2025 Initiated: April 21, 2025 #D-0539-2025

Product Description

EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.

Reason for Recall

CGMP Deviations; potential temperature excursions due to transit delays

Details

Units Affected
2 Pre-filled syringes
Distribution
Within the U.S - OH, VA, FL.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 2 Pre-filled syringes.
Why was this product recalled?
CGMP Deviations; potential temperature excursions due to transit delays
Which agency issued this recall?
This recall was issued by the FDA Drug on July 30, 2025. Severity: Moderate. Recall number: D-0539-2025.